Supriya Lifescience Community

NSEI:SUPRIYA Community

1 Narratives written by author
0 Comments on narratives written by author
12 Fair Values set on narratives written by author

Supriya Lifescience

AN

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

Expansion Into Regulated Markets And CMO/CDMO Opportunities To Strengthen Future Prospects

Key Takeaways Supriya Lifescience's product launches and market penetration in regulated regions aim to enhance revenue growth and net margins. Strategic capacity expansion and decreased reliance on China signal potential long-term earnings and margin stability.

₹740.00

FV

1.0% undervalued

20.76%

Revenue growth p.a.

0

0

7

6 days ago